Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2013 14:20 ET | Source: Bio Green Med Solution, Inc.

Combination Potential of Cyclacel's Sapacitabine and Seliciclib Reported at AACR

BERKELEY HEIGHTS, N.J., April 9, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced updated data from an open label,...
April 08, 2013 07:00 ET | Source: Bio Green Med Solution, Inc.

AACR Press Conference Highlights Combination Potential of Two Cyclacel Drugs

WASHINGTON, April 8, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced that the American Association of Cancer Research...
April 04, 2013 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene and Dismissal of All Claims in Their Patent Litigation

BERKELEY HEIGHTS, N.J., April 4, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced that it has entered into a definitive...
April 03, 2013 14:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual Meeting

BERKELEY HEIGHTS, N.J., April 3, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
March 27, 2013 16:01 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results

BERKELEY HEIGHTS, N.J., March 27, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today its financial results and business...
March 22, 2013 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel to Announce Year-End and Fourth Quarter 2012 Financial Results

BERKELEY HEIGHTS, N.J., March 22, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
February 12, 2013 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Announces Grants of New U.S. & European Patents Covering Sapacitabine Used in Combination With HDAC Inhibitors

BERKELEY HEIGHTS, N.J., Feb. 12, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
February 04, 2013 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference

BERKELEY HEIGHTS, N.J., Feb. 4, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company) today announced that the Company will present at the 15th...
January 07, 2013 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Reviews 2012 Achievements and Announces Key Business Objectives for 2013

- SEAMLESS DSMB recommended that the study should continue as planned - - Company to Present at the Biotech Showcase™ 2013 Conference on Monday January 7, 2013 at 3:15 pm PT - BERKELEY...
December 17, 2012 07:15 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Enters Into a $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

BERKELEY HEIGHTS, N.J., Dec. 17, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...